SION

SIONNA THERAPEUTICS INC

SION·829401108·US·Common Stock·Healthcare - Biotechnology-Activist

SION (SIONNA THERAPEUTICS INC) is held by 76 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($397.1M), VIKING GLOBAL INVESTORS LP ($128.1M), JENNISON ASSOCIATES LLC ($58.2M). Net institutional sentiment: Mixed.

76
Holders
(4 Elite)
$1B
Total Value
63% (71)
Consensus
45 buying - 26 selling
13F: Insider & Congress:
SIONSmart Money Verdict
View all
Held by 76 funds
4 elite
Who's Trading
InsiderFJFitzpatrick JenniferSell $447KJul 6, 2026
ActivistVIKING GLOBAL INVESTORS LPVIKING GLOBAL INVESTORS LP7.1%May 15, 2026
ActivistQIQatar Investment Authority4.5%May 12, 2026
InsiderTAThompson Peter A.Sell $8.5MMay 11, 2026
InsiderOLORBIMED ADVISORS LLCSell $8.5MMay 11, 2026
InsiderTAThompson Peter A.Sell $2.7MMay 8, 2026
InsiderOLORBIMED ADVISORS LLCSell $2.7MMay 8, 2026
InsiderOLORBIMED ADVISORS LLCSell $2.2MMay 7, 2026
InsiderTAThompson Peter A.Sell $2.2MMay 7, 2026
ActivistOAORBIMED ADVISORS LLC6.6%Apr 20, 2026
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
9.9M$397.1M4.2%+291.78%
0
Unchanged
3.2M$128.1M0.4%+281.08%
0
Increased
1.5M(+30.1%)$58.2M0.0%+103.77%
37
Increased
1.5M(+18.9%)$53.7M0.0%+197.38%
35
Increased
1.3M(+0.3%)$52M0.0%+72.54%
29
Increased
1.2M(+7.3%)$46.8M0.0%+13.30%
31
New
1M$41.3M0.0%+32.85%
40
Decreased
756,376(-9.0%)$30.3M0.0%+144.72%
0
Increased
756,227(+9.1%)$30.3M0.0%+30.60%
31
Decreased
564,175(-32.8%)$22.6M0.0%+262.87%
0
Unchanged
400,000$16M0.1%+291.78%
0
Increased
389,872(+2.6%)$15.6M0.0%+127.25%
29
Increased
263,174(+625.6%)$10.6M0.0%+34.33%
45
Increased
255,636(+220.1%)$10.2M0.0%+24.52%
45
New
236,813$9.5M0.0%+32.85%
38
Unchanged
175,483$7M0.0%+291.78%
0
New
150,000$6M0.0%+32.85%
38
Increased
147,641(+65.6%)$5.9M0.0%+50.32%
40
New
142,081$5.7M0.0%+32.85%
37
Increased
140,641(+74.6%)$5.6M0.0%+47.05%
41

Showing 1-20 of 80

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used